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a b s t r a c t 
The dynamics of donor speciﬁc human leukocyte antigen antibodies during early stage after kidney trans- 
plantation are of great clinical interest as these antibodies are considered to be associated with short and 
long term clinical outcomes. The limited number of antibody time series and their diverse patterns have 
made the task of modelling diﬃcult. Focusing on one typical post-transplant dynamic pattern with rapid 
falls and stable settling levels, a novel data-driven model has been developed for the ﬁrst time. A varia- 
tional Bayesian inference method has been applied to select the best model and learn its parameters for 
39 time series from two groups of graft recipients, i.e. patients with and without acute antibody-mediated 
rejection (AMR) episodes. Linear and nonlinear dynamic models of different order were attempted to ﬁt 
the time series, and the third order linear model provided the best description of the common features 
in both groups. Both deterministic and stochastic parameters are found to be signiﬁcantly different in 
the AMR and no-AMR groups showing that the time series in the AMR group have signiﬁcantly higher 
frequency of oscillations and faster dissipation rates. This research may potentially lead to better under- 
standing of the immunological mechanisms involved in kidney transplantation. 
© 2016 The Authors. Published by Elsevier Inc. 
This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ). 
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0. Introduction 
Kidney transplantation is proven to be the best treatment for
enal failure and success is dependent on the reaction of the im-
une system primarily against human leukocyte antigen (HLA)
roteins of the transplant. The HLA system is extremely complex;
t is unusual to ﬁnd two unrelated individuals with the same HLA
ype and only a minority of the transplants in the UK are fully
atched for HLA tissue proteins [1] . Conventional transplantation
s facilitated by immunosuppression which targets cellular compo-
ents of the immune system. 
A signiﬁcant number of patients develop antibodies to HLA fol-
owing exposure to non-self HLA from pregnancy, blood trans-
usion or previous kidney graft [2,3] . These antibodies exist as
ultiple isoforms but it is Immunoglobulin G (IgG) which is
eemed to be most detrimental to transplant outcome [4] . Such∗ Corresponding author. Tel.: +44 2476528242. 
E-mail address: n.khovanova@warwick.ac.uk (N. Khovanova). 
a  
r  
H  
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025-5564/© 2016 The Authors. Published by Elsevier Inc. This is an open access article u
Please cite this article as: Y. Zhang et al., A new data-driven model for 
tation, Mathematical Biosciences (2016), http://dx.doi.org/10.1016/j.mbsgG, termed donor-speciﬁc antibody (DSA), when directed at a cur-
ent or prospective donor HLA, can persist for years and are a bar-
ier to transplantation because they can cause immediate, early,
nd late rejection. Safe transplantation of potential recipients with
igh levels of circulating DSAs is an ongoing problem resulting in
rolonged waiting times for transplantation [5] . Ideally, such re-
ipients should receive a transplant from an antibody compatible
onor but because of a donor shortage this is seldom possible. 
Innovative clinical protocols and techniques have been devel-
ped [5–7] to allow transplantation of such highly sensitised pa-
ients by removal of DSAs immediately before the transplant [2,8] .
omplete elimination of preformed HLA DSAs is not possible and,
ecause of immunological memory, post-transplant DSA resynthe-
is can still result in severe acute antibody-mediated rejection
AMR) and an increased risk of graft loss. The mechanisms un-
erlying the control of antibody production are poorly understood
nd treatments given to patients with AMR can be ineffective. In
ecent years, a number of publications [9–11] have conﬁrmed that
LA antibodies are the major cause of acute AMR and chronic graftnder the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ). 
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pfailure. Even though the risk of acute rejection and chronic graft
failure is positively correlated with high DSA levels, the associa-
tion can vary between patients. In the acute setting, transplanta-
tion across very high DSA levels may result in 50% graft loss, but
data based on the currently used antibody detection assays cannot
reliably predict the outcome [12] . Likewise, in the chronic setting
there is not always a clear relationship between the occurrence of
AMR and the detection of circulating DSAs [13,14] . 
Our group has investigated early DSA dynamics in these high
risk transplants because the nature of their response is likely to
profoundly affect clinical outcomes [2,8,15] . We have observed that
the dynamic behaviour of post-transplant DSAs varies from case to
case, and even different DSAs in the same patient (targeting differ-
ent HLA) show diverse patterns. Development of a strong mathe-
matical approach to describe the dynamics of the preformed DSAs
has not yet been attempted. This is because white box models, i.e.
physiological models, are not yet feasible due to the complexity
of underlying immunological responses to transplants. Data-driven
models, on the other hand, require both an accurate method of
measuring the DSAs in human sera and an appropriate mathemat-
ical framework for the development of the model from limited and
complex sets of data. 
The possible mechanisms underlying changes in the levels of
DSAs are complex and the DSAs levels cannot easily be measured
in the laboratory. DSA levels may change because of rises and falls
in the rate of production. This itself could be related to changes
in the populations of antibody-producing cells (plasma cells and
memory B lymphocytes), and these cells could be formed pre-
transplant and/or recruited from less mature lymphocyte popula-
tions post-transplant [16] . Falls in the levels of DSA post-transplant
are very interesting, as these may occur much faster than the ‘nat-
ural’ rate of antibody clearance from the body (thought to have a
half life of about 20–30 days [17] ). Mechanisms associated with re-
ductions in antibody levels could include absorption of antibodies
onto HLA molecules on the graft [18] – it is known that the levels
of HLA on a graft may increase post-transplant, but this cannot yet
be quantiﬁed. Some HLA is shed by the graft, so antibodies could
be absorbed in the circulation. It is known that one physiological
method used by the body to control antibody levels is to produce
antibodies that block other antibodies (idiotypic antibodies), and
production of idiotypic antibodies could explain the falls in DSA
post-transplant [19] . However, as with other potential regulatory
mechanisms, it is currently hard to measure idiotypic antibodies
accurately. Thus, mathematical modelling of changes in DSA levels
may indicate where the effort s involved in developing new labora-
tory assays might be best directed, and once appropriate assays are
available, the modelling may help in the interpretation of results of
the assays at different time points. This could be particularly im-
portant in relation to falls in DSA levels, since this is a key clinical
objective that is currently not achievable in clinical practice. 
It has recently been recognised by the transplant commu-
nity [2,20] that post-transplant screening for anti-HLA antibodies
could be an important tool for monitoring of transplant recipients.
Highly sensitive and speciﬁc assays using puriﬁed HLA protein
have been developed in recent years. This development in assays
meets the increasing need for monitoring post-transplant DSAs
[21] and opens up opportunities to develop data-driven mathemat-
ical models for the evolution of antibodies after transplantation. 
A unique dataset with detailed antibody measurements span-
ning three to six months, starting around ten days before trans-
plantation has been obtained by our group. A previous analysis
[2] of these data revealed various patterns of antibody dynam-
ics, both with or without acute AMR. Some DSA time series show
a rapid rise during the ﬁrst two weeks followed by a rapid fall
to almost undetectable levels, which then remain low. This ﬁnd-
ing is striking: in many of these patients, the DSAs had persistedPlease cite this article as: Y. Zhang et al., A new data-driven model for 
tation, Mathematical Biosciences (2016), http://dx.doi.org/10.1016/j.mbsor many years before transplantation, and therapies used exper-
mentally have been unable to stop antibody production before
ransplantation. A better understanding of this phenomenon could
herefore have practical beneﬁts. 
The aim of this work is therefore to describe the pathologi-
al early antibody response in mathematical terms and we hy-
othesize that this approach might enable a more intelligent ap-
lication of laboratory testing and suggest therapeutic approaches
o selectively control this antibody response and improve clini-
al transplant outcomes. To take full advantage of the data avail-
ble, we have developed a data-driven model based on differen-
ial equations that reﬂects the continuous nature of the underly-
ng immunological process [22] . The usefulness of the model for
lassiﬁcation between patients with and without AMR was also
nvestigated. 
Data from the patients in this series were analysed in relation
o a single outcome measure, namely the occurrence of early acute
MR. This is a key early outcome in antibody incompatible trans-
lantation (AIT), as it is associated with the levels of immunosup-
ression required in the early post-transplant period, and is also
ssociated with short and long term graft survival. 
The structure of the paper is as follows. Section 2 gives de-
ails on the data and presents visual analysis of the variety of
ynamic antibody responses to transplantation. Section 3 explains
he methodology for model formulation and parameter estimation.
ection 4 presents the ﬁnal model and detailed analysis of systems
arameters. Section 5 summarises the results, justiﬁes the need for
urther work and outlines the relevance of the model for kidney
ransplant management. 
. Data description and visual analysis of dynamic patterns 
Data from twenty-three patients who underwent renal AIT
t University Hospitals Coventry and Warwickshire (UK) between
003 and 2012 were analysed in this study. The data were com-
rised of time series of DSA evolution over a period of about ten
ays before and six months after transplantation. Serum samples
or DSA analysis were taken almost daily in the ﬁrst three to four
eeks, as most dynamic behaviour occurs during that period, and
ampling became more sparse later when the antibodies tended
o be more stable. Antibody levels were measured using the mi-
robead assay manufactured by One Lambda Inc (Canoga Park, CA,
SA), analysed on the Luminex platform (XMap 200, Austin, TX,
SA). The assay measures the Mean Fluorescence Intensity (MFI)
hich corresponds to antibody level although their relationship is
inear only over a limited range. As described in [2] , when the MFI
alue is higher than 10,0 0 0 AU (Arbitrary Units) and below about
0 0 0 AU, the linear correlation breaks. 
Some of the patients had multiple DSAs targeting different HLA,
o the total number of post-transplant time series available for
his analysis was thirty-nine. Twenty-seven DSA time series belong
o fourteen patients that experienced episodes of acute AMR in
he ﬁrst thirty days after transplantation (AMR group), and twelve
SA time series belong to the other nine patients who did not have
n episode of AMR (no-AMR group). Rejection episodes were di-
gnosed by renal biopsy or clinically if there was rapid onset of
liguria with a rise in both serum creatinine and DSA levels [2] . In
atients receiving HLA antibody-incompatible grafts, the incidence
f AMR was 30–40% [15] . Although AMR can be severe and can
ventually result in graft failure, it usually develops slowly over a
eriod of several days. This gives an opportunity to detect AMR at
n early stage and treat it, resulting in better outcomes [8] . The
roup characteristics and details of therapy have previously been
escribed [2] . A smaller dataset including twenty-one time series
rom the ﬁrst twelve patients in the cohort was considered in our
reliminary study [23] . post-transplant antibody dynamics in high risk kidney transplan- 
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Fig. 1. Measured time series illustrating individual DSA changes in the no-AMR group. Markers correspond to each measurement point. MFI = mean ﬂuorescent intensity. 
Fig. 2. Measured time series illustrating individual DSA changes in the AMR group. Markers correspond to each measurement point. MFI = mean ﬂuorescence intensity. 
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o  Visual examination of the time series reveals diverse dynamic
ehaviour of DSAs. Figs. 1 and 2 show some examples of the pat-
erns from the no-AMR group and the AMR group, respectively. As
ome patients had multiple DSAs, the case number in these ﬁg-
res and in the corresponding text is followed by the DSA type.
or example, in Fig. 2 , patient 36 had two DSAs, HLA-A24 and HLA-
R17, comprising two different time series: case 36 HLA-A24 (case
6 A24 for short) and case36 HLA-DR17 (case 36 DR17 for short).
retransplant antibody removal can be seen to reduce total DSA
evels due to cycles of double ﬁltration plasmapheresis. Typically,
etween two and ﬁve alternate day sessions were performed. 
The initial drop is typically followed by a rapid rise in DSA
hich usually occurs with a lag of a few days after transplanta-
ion and is caused by two factors: plasmapheresis stopping and an
ncreased rate of DSA synthesis due to an immunological memory
esponse. After the peak levels a diversity of dynamic patterns is
oticeable: antibody levels do not follow a common route, vary-
ng from case to case, and even differing for different DSAs in the
ame patient. In some cases there is a rapid fall in DSA to a steady
tate, corresponding to a low (almost zero) level of DSA, and this
s typically reached within the ﬁrst month after operation. Such
atterns are observed in both no-AMR and AMR groups: case 34Please cite this article as: Y. Zhang et al., A new data-driven model for 
tation, Mathematical Biosciences (2016), http://dx.doi.org/10.1016/j.mbsboth B62 and B60) and case 28 in Fig. 1 , and case 36 DR 17 in
ig. 2 . In other cases the dynamics of the fall after the peak are fol-
owed by another rise, and antibodies do not settle at a low level
ithin the ﬁrst three months after operation: case 59 in Fig. 1 ,
ase 36 A24 and cases 61 and 69 in Fig. 2 . They either demon-
trate a slow dynamic around a certain constant level (case 61 in
ig. 2 ) or change dramatically over the ﬁrst three months (case 59
n Fig. 1 and case 69 in Fig. 2 ). There is no obvious relationship be-
ween these dynamical patterns, steady state levels and the occur-
ence of AMR episodes. In some cases, as shown above, low steady
tate levels are observed in the no-AMR group and higher levels
r dramatic changes are noticeable in the AMR group. There are
lso cases with the absence of AMR despite high levels of DSA, or
resence of AMR despite low DSA levels. Finally, some patients
e.g. case 36 in Fig. 2 ) rejected the kidney, but had multiple DSAs
ith one type that rose after the initial fall post-transplant (A24)
nd another type that kept falling to a low steady level (DR17).
his visual analysis demonstrates that there is no certain associa-
ion between higher levels of post-transplant DSA and the occur-
ence of the rejection episodes. 
The aim of this study is to analyse these dynamical patterns in
rder to propose a set of characteristics capable of discriminatingpost-transplant antibody dynamics in high risk kidney transplan- 
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this study, we are particularly interested in the DSA dynamics af-
ter the ﬁrst peak value down to an almost zero level, i.e. focus is
on the typical pattern of a rapid fall that occurs in most of the pa-
tients with and without AMR episodes. Falls in the serum levels of
HLA DSAs after kidney transplantation are of great clinical interest,
as they are associated with resolution of rejection and good long
term outcomes in patients at high risk of graft loss [15] . 
3. Models and methods 
3.1. Data ﬁtting and model selection 
As seen from the preliminary observations of the dynamic
patterns, the HLA antibody response to the transplanted kidney
is a complex immunological process, nonlinear and stochastic in
general. Time series available for analysis are complex and one-
dimensional: only one variable as a function of time (MFI levels)
is available representing a response of the entire biological system
to external stimuli. These characteristics pose a set of challenging
questions with respect to the order of the system and the number
of parameters to be used in the model. It is also unclear whether
the system equation should be linear or nonlinear, stochastic or
deterministic, and what would be the most appropriate modelling
approach to identify system parameters in the situation where no
preliminary knowledge of the model is available. Although we only
consider the falling part of MFI level dynamics, all the above ques-
tions remain. 
3.1.1. Exponential ﬁtting 
It can be noticed that the falling MFI dynamics of HLA DSA after
the peak value is a relaxation process, the simplest theoretical de-
scription of which is an exponential law. Initially the curve ﬁtting
tool (Cftool) in Matlab [24] was used to ﬁt each of the thirty-nine
DSAs. Some of the time series were correctly described by this ap-
proach; however, the use of superposition of exponential functions
could not correctly describe all the cases with and without AMR in
our cohort. As the next step, instead of exponential functions, i.e.
solutions of dynamic equations, dynamic mathematical models in
the form of differential equations were considered. 
3.1.2. Form of the model: linear/nonlinear and stochastic terms 
A general form of an n th order nonlinear differential equation
with coeﬃcients in the form of a polynomial function have been
considered. Initially two stochastic terms were included to repre-
sent noise in the system equations. Measurement noise is added
due to uncertainty in measured data, and the dynamic noise ac-
counts for any other hidden properties not captured by the model.
Thus, DSA falls after the initial rise (to a peak level) in the early
post-transplant period can be described by the following model: 
d n 
d t n 
x t + 
n −1 ∑ 
i =0 
f i +1 (x t ) 
d i 
d t i 
x t + f 0 (x t ) = ηt (1)
y t = x t + ε t (2)
Eq. (1) is an evolution equation of n th order, where x t is a function
of t that describes the MFI dynamics, and y t is the measured MFI
time series. ηt is system noise, and ε t is measurement noise. Each
noise was modelled as Gaussian-distributed white noise with zero
mean and intensity (variance) of I η and I ε , respectively. f i +1 (x t )
(i = 0 , 1 , . . . , n − 1) are polynomial functions of x t . The derivative
of order zero of x t is deﬁned to be x t itself. f 0 ( x t ) is deﬁned as
−θ0 for convenience. The order of the system equation n is to be
decided together with unknown parameters of functions f i+1 ( x t ). n
initial conditions are required to obtain a closed form solution. Please cite this article as: Y. Zhang et al., A new data-driven model for 
tation, Mathematical Biosciences (2016), http://dx.doi.org/10.1016/j.mbsModel M n constituting Eqs. (1) and (2) covers a variety of dy-
amic patterns depending on the order of the system n . A more
omplex model may be able to explain a wider range of system
ehaviour in the data at the risk of overﬁtting. 
.2. Model and parameter identiﬁcation 
In the current work, for DSA time series, nonlinear and lin-
ar stochastic dynamic hierarchical models were developed us-
ng a variational Bayesian inference approach [25] for both model
nd parameter identiﬁcation. Both the form and parameters of the
odels were identiﬁed using the SPM9 toolbox [26] (freely avail-
ble online) for MATLAB [24] . This variational Bayesian toolbox
26] allows accounting for both types of stochastic terms: measure-
ent noise and system noise. 
Starting from the ﬁrst order model M 1 ( n = 1 in Eq. (1) ), the
rder n was increased until the model M n ﬁtted the data suﬃ-
iently well – satisfy the criteria given in Section 3.3 . The varia-
ional Bayesian learning algorithm [25] was modiﬁed to our spe-
iﬁc data to calculate probabilities p ( y t | M ) (where M is M 1 , M 2 ,
, M n ) of observing the time series y t given different models M ,
o that the model with the highest value of p ( y t | M ) could be se-
ected for that speciﬁc DSA time series. Attention has to be paid
o the features in the dataset that can be explained by a model
ith a higher order but cannot be explained by the model with
 lower order, and to decide if the features are general enough to
ake the ﬁnal decision on the order for all DSA time series under
nvestigation. 
For each model candidate, the value of the probability p ( y t | M ),
hich is also referred to as the model evidence [27] , was ap-
roached by iteratively optimising the states of the system and
odel parameters until a local maximum value of p ( y t | M ) was
eached. This procedure is embedded into the variation Bayesian
ptimisation algorithm [27] . Brieﬂy, to infer multiple elements of
he hierarchical model, i.e. system states, parameters (related to
he deterministic terms in the equation), and hyperparameters (re-
ated to the stochastic terms) each element is optimised one by
ne while the rest of the elements are kept ﬁxed. There are two
teps in this optimisation procedure. Firstly, assuming the elements
parameters and the states) are conditionally independent of each
ther, the combined distribution can be factorised into indepen-
ent partitions of each element distribution, which is known as
he mean-ﬁeld approximation, i.e. the combined distribution of all
he elements was approximated by the product of individual ele-
ent distributions [27] . Secondly, the distribution of each individ-
al parameter/state was approximated by the ﬁrst two moments
mean and variance) known as Laplace approximation [27] . The
ean-ﬁeld approximation and the Laplace approximation allow for
n iterative update of the parameters and the states by applying
ariational calculus. The logarithm of p ( y t | M ) is known as ‘free en-
rgy’ F(θ, y t ) , a term borrowed from statistical physics [25] . The
ree energy was maximised, and, among other criteria (normalised
oot mean square error and the stability of the immune response,
oth of which are discussed in the next section), deﬁned the good-
ess of ﬁt. 
This Bayesian approach not only provides the most probable
alues of the parameters but also accounts for the uncertainties
n the parameters. The prior information regarding the parameters
s also taken into account. Such information on possible parame-
er values was not available to us, and therefore the mean values
f the parameter priors were set to zero. To allow the algorithm
o search in a relatively wide region for the optimal parameters,
ll variances were set to be 10 4 , i.e. priors with wide distributions
ere considered. Both noise precisions, which are inversely propor-
ional to noise intensities, were modelled by a gamma distribution
ith two hyperparameters (shape ηa , ε a and rate η , ε ). Weaklyb b 
post-transplant antibody dynamics in high risk kidney transplan- 
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e  nformative Jeffreys priors, as described in [28] , were chosen for
he precisions of the noise, with both shape and rate parameters
et to 1. The initial conditions were all modelled as Gaussian dis-
ributions. The prior means of the initial conditions were deﬁned
rom the measurement time series, and the prior variances were
et to 10 4 . 
.3. Model selection criteria 
The following four criteria were applied to identify the best ﬁt-
ing model. 
1. The free energy F has been maximised by tuning system pa-
rameters in an iterative manner for each model. Note that
decision making based on the comparison of free energy of
any two models with different orders could be problematic
due to the heavy penalisation of the model complexity em-
bedded in the variational Bayesian method as explained in
[27] . Increasing the order of the system by one would not
only increase the degree of freedom in the parameter space,
but also increase the dimension of the system states. This
leads to a dramatic decrease in the free energy, which could
be an order (or several orders) greater than the free energy
difference between models of the same order. Therefore, the
free energy criteria was only used to compare the models of
the same order. For models with different orders, criterion
2, as below, was utilised. 
2. Normalised Root Mean Squared Error (NRMSE) was used to
compare the models with different orders for each individ-
ual time series. Inferred parameters θ i were applied back to
the system equation to generate time series without stochas-
tic terms, i.e. deterministic solution. Note that because pa-
rameters were identiﬁed in the form of normal distribu-
tions, the most probable (mean) value of parameters were
plugged into the system equation. Root Mean Squared Er-
ror ( RMSE ) between the measurement MFI time series y t and
the inferred deterministic time series ˆ yt can be calculated as
follows: 
RMSE = 
√ ∑ n 
t=1 ( ˆ  yt − y t ) 2 
n 
(3) 
NRMSE accounts for the different heights of the peaks for
each DSA time series and is found by dividing the RMSE
by the maximal MFI value for a given DSA time series. The
model with the lowest value of NRMSE describes the data
most accurately. For the model to be deemed satisfactory,
NRMSE should not exceed the value of 0.15 (or 15 %) as it is
known that the inter-assay coeﬃcient of variability for DSA
measurements is around 10–30% [29] . 
3. Generic form . As the entire aim was to ﬁnd a model capable
of capturing the common patterns in all time series, a model
that could only describe some of the DSA time series was
disregarded. 
4. System stability . The model has to have a unique stable
steady state, which implies that the system’s response de-
cays with time. This has been checked via calculations of
the real parts of corresponding eigenvalues which have to
be negative for stability. Note, even though the steady state
of the immune homoeostasis was disturbed by transplanta-
tion, the antibody levels settled rapidly to a new steady state
except for the extreme cases (example case 69 HLA-DR53 in
Fig. 2 ), but consideration of such cases is out of the scope ofthis work. t  
Please cite this article as: Y. Zhang et al., A new data-driven model for 
tation, Mathematical Biosciences (2016), http://dx.doi.org/10.1016/j.mbs.4. Statistical analysis 
Statistical analysis of model parameters was performed using
he Wilcoxon rank sum test. The null hypothesis of no difference
etween the groups of interest was tested at the 5% signiﬁcance
evel, and the results are presented as p -values. Statistical analysis
f the differences in NRMSE between two models was performed
sing the one sample t -test, which assesses the normality of data
ith zero mean and unknown variance at the 5% signiﬁcance level.
he result is presented as p -values. 
. Results and discussions 
.1. Model selection 
.1.1. Comparison of linear models of different orders 
Linear models with different system orders are considered ﬁrst.
q. (1) in Section 3.1.2 transforms into a linear differential equa-
ion when f i +1 (x t ) are constants, with constant parameters θ i 
(i = 0 , 1 , . . . , n − 1) , where f n (x t ) = θn , . . . , f 2 (x t ) = θ2 , f 1 (x t ) = θ1 .
 0 ( x t ) is deﬁned as −θ0 for convenience. 
A ﬁrst order linear model was considered ﬁrst, and it did not
how good performance. Then linear models with higher system
rders were investigated. In this section, we present the results
f system and parameter identiﬁcation by comparing solutions for
inear ﬁrst, second and third order dynamic equations only: 
odel 1 (M 1 ) : 
d x t 
d t 
+ θ1 x t − θ0 = 0 (4) 
odel 2 (M 2 ) : 
d 2 x t 
d t 2 
+ θ2 d x t 
d t 
+ θ1 x t − θ0 = 0 (5)
odel 3 (M 3 ) : 
d 3 x t 
d t 3 
+ θ3 d 
2 x t 
d t 2 
+ θ2 d x t 
d t 
+ θ1 x t − θ0 = 0 (6)
ote if the third order equation had not been successful, the pro-
edure would have continued to account for nonlinearities (pre-
ented in Section 4.1.2 ) ﬁrst and then increase the order of the
ystem until a suitable solution is found. 
Initially not only the measurement noise ε t (as in Eq. (2) ) but
lso the system noise ηt (as in Eq. (1) ) was included in the mod-
ls. It was found that for all DSA time series, models without sys-
em noise have larger free energy compared with the counterpart
athematical representations containing both types of stochastic-
ty. The beneﬁt – improved ﬁtting – obtained by using the more
omplex model with system noise does not exceed the penalty
ntroduced by adding two degrees of freedom in the parameter
pace. Therefore, we excluded the system noise from the models
nd this is reﬂected on the zero right hand side of the Eqs. (4) –(6) .
Typical ﬁttings for four DSA time series, one from the no-AMR
roup and the other three from the AMR group, by the three sug-
ested models (4) –(6) are shown in Fig. 3 . The results for models
 1 – M 3 in Fig. 3 (a) and (c) show a winning model candidate M 3 .
ven though (a) is from a patient in the no-AMR group and (c) is
rom a patient in the AMR group, both time series show oscilla-
ions after day 30. M 1 failed to describe the dynamics of both time
eries as indicated by large NRMSE values in Table 1 : NRMSE =
 . 272 and NRMSE = 0 . 090 . M 2 successfully described the initial
alls for both time series, but failed to capture the oscillations in
SA after day 30, which is also conﬁrmed by the large NRMSE
alue of 0.053 and 0.096 ( Table 1 ). M 3 captured successfully both
he falling part and the later trend with smaller NRMSE values of
.014 and 0.053. Fig. 3 (b) exhibits different dynamics with a cluster
f data around day 20. This is a common feature observed in the
ajority of time series in both AMR and no-AMR groups, and re-
uires special attention. The temporary stall of falling could not be
xpressed by using M 1 or M 2 ; however, M 3 successfully depicted
he sudden changes in falling as shown in the magniﬁed box 1post-transplant antibody dynamics in high risk kidney transplan- 
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Fig. 3. Typical ﬁtting results compared among the three models M 1 – M 3 for (a) HLA-B60 (case 52) for a patient from the no-AMR group; (b) HLA-DRB3 
∗01 for a patient 
(case 14) from the AMR group; (c) HLA-A32 for a patient (case 16) from the AMR group; (d) HLA-A2 for a patient (case 17) from the AMR group. The measured values are 
indicated by circles. 
Table 1 
Summary of the NRMSE values for 3 
models corresponding to the four ex- 
ample datasets in Fig. 3 . 
NRMSE 
M 1 M 2 M 3 
( a ) 0.272 0.053 0.014 
( b ) 0.083 0.085 0.013 
( c ) 0.090 0.096 0.053 
( d ) 0.088 0.071 0.073 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Boxplot of the difference between the NRMSE of M 2 and NRMSE of M 3 . 
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a  in Fig. 3 (b). Further, the ﬁttings by M 1 and M 2 were almost in-
distinguishable after day 70, and both models underestimated the
settling level of DSAs. The ﬁtting by M 3 otherwise correctly esti-
mated the settling level and gave a better description of another
clustered region around day 30 (see magniﬁed box 2 in Fig. 3 (b)).
Thus, M 1 and M 2 were ruled out based on their incapability of de-
scribing the important features, and the higher order model M 3 
was chosen. 
The same approach was applied to all the other DSA time se-
ries. In 32 out of 39 cases, the NRMSE value of M 3 was the small-
est among the three models. In the other 7 cases, the NRMSE value
of M 2 was comparable with the NRMSE value of M 3 . An example
is shown in Fig. 3 (d) where the ﬁttings by M 2 and M 3 were indis-
tinguishable from each other, with NRMSE values given in Table 1 .
To compare the NRMSE values between M 2 and M 3 across all 39
cases, the NRMSE value of M 3 was subtracted from the NRMSE
of M 2 , and the differences for all time series are shown in the
boxplot Fig. 4 . The differences in NRMSE between the two mod-
els were tested by the one-sample t -test at the signiﬁcance level
of 0.001, and the mean value was found to be signiﬁcantly larger
than zero. Therefore, M 3 was selected as the best model across the
cohort with the dynamic equation in the form (6) . Note that the
NRMS E M 2 − NRMS E M 3 values for the seven cases with very close
NRMSE values, mentioned above, are located around the zero value
in Fig. 4 . Please cite this article as: Y. Zhang et al., A new data-driven model for 
tation, Mathematical Biosciences (2016), http://dx.doi.org/10.1016/j.mbs.1.2. Nonlinear versus linear 
Nonlinearity was introduced into the second order model in
he form of polynomial nonlinear coeﬃcients f 1 ( x t ) or f 2 ( x t ) in
q. (1) using the approach of [23,30,31] . It was acknowledged that
 linear description is preferable over nonlinear if this does not
ncrease the number of unknown parameters dramatically. Conse-
uently, the maximal number of unknown parameters in the sec-
nd order nonlinear model was kept comparable with the num-
er of parameters of the third order linear equation, i.e. no more
han 4. Under this condition, two nonlinear models were consid-
red: model NM 1 with nonlinearity in the damping term ( f 1 (x t ) =
 1 x t + θ1 , f 2 (x t ) = θ2 ) and model NM 2 with nonlinearity in the
 t term ( f 1 (x t ) = θ1 , f 2 (x t ) = k 2 x t + θ2 ). The corresponding system
quations are as follows: 
M 1 : 
d 2 x t 
d t 2 
+ θ2 d x t 
d t 
+ (k 1 x t + θ1 ) x t − θ0 = 0 (7)
M 2 : 
d 2 x t 
d t 2 
+ (k 2 x t + θ2 ) d x t 
d t 
+ θ1 x t − θ0 = 0 (8)
An example of the ﬁttings of the time series from Fig. 3 (c) by
onlinear models NM 1 and NM 2 is shown in Fig. 5 . From Fig. 5 ,
either NM 1 nor NM 2 captured the dynamic features of the time
eries. The NRMSE criterion was applied here for models of differ-
nt order: both NRMSE values (0.080 for NM 1 and 0.067 for NM 2 )
re larger than 0.053 for M . Additionally it is clear that the ﬁtting3 
post-transplant antibody dynamics in high risk kidney transplan- 
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Fig. 5. Fitting results compared between the two nonlinear models NM 1 and NM 2 
and the linear model M 3 for the time series shown in Fig. 3 (c). The measured values 
are indicated by circles. 
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n  y NM 2 leads to an unstable solution. Therefore, linear model M 3 
 Eq. 6 ) outperformed both NM 1 and NM 2 , and was chosen as the
nal model. This example is a typical (representative) ﬁtting for all
he other time series in the cohort. 
.2. Analysis of the inferred parameters 
The inferred parameters ( θ0 , θ1 , θ2 and θ3 ) of the selected
odel M 3 have been compared between the two groups (AMR
nd no-AMR) for meaningful differences. The results are presented
n Fig. 6 (a)–(d) in the form of boxplots. For all four parameters,
he ranges of the parameter values are much wider in the AMR
roup compared with the no-AMR group, indicating more diverse
ynamic behaviour of DSAs in the AMR group. The Wilcoxon rank
um test showed statistically signiﬁcant differences in the median
alues between the AMR and the no-AMR group for all four pa-
ameters, which conﬁrmed the results of our preliminary study
23] with fewer cases. 
Even though the values of the parameters do not have direct
linical interpretations, which is one of the main drawbacks of
ata-driven modelling in biomedical research, a certain combina-
ion of the parameters indicates important features of the system
nder investigation. The ratio θ0 / θ1 from Eq. (6) deﬁnes the set-
ling level of DSA, which is of clinical interest. Kidney transplan-
ation constitutes a major disturbance in the immune system, and
he system should settle down to a new homoeostatic equilibrium
fter the transient response to the transplanted organ. A success-
ul transplantation is usually characterised by a new stable steady
tate with low DSA levels (ideally zero, or below the limit of detec-a b
c d
Fig. 6. Boxplot for the inferred 
Please cite this article as: Y. Zhang et al., A new data-driven model for 
tation, Mathematical Biosciences (2016), http://dx.doi.org/10.1016/j.mbsion of the assay). From the comparison between the AMR and no-
MR groups, the majority of the settling MFI values in both groups
re less than 10 0 0 AU, indicating low DSA settling levels. The high-
st settling level in the no-AMR group is 3862 AU, compared with
he level of 5783 AU in the AMR group. The lowest settling level
n the no-AMR group is 22 AU, compared with the level of 27 AU
n the AMR group. There is no signiﬁcant difference in the median
alue of θ0 / θ1 between the groups with a p -value of 0.5 (300 AU
n the no-AMR group, 425 AU in the AMR group), which means
hat a DSA time series from the AMR group does not necessarily
ave a higher settling level. However, signiﬁcant difference in θ0 
nd θ1 separately between the groups shown in Fig. 6 implies that
he dynamic behaviour of DSAs in the AMR group might be con-
rolled by more complex and diverse underlying mechanisms. 
Such detailed analysis of the parameters of the models devel-
ped allows for enhanced understanding of the clinical character-
stics which are most important for successful outcome in this high
isk form of transplantation. Our ﬁndings may facilitate the forma-
ion of an accurate pre-transplant risk proﬁle which predicts AMR
nd allows the clinician to intervene at a much earlier stage. Given
hat AMR in the early post-transplant period has been shown to
ead to worse long-term graft outcome any strategy to prevent
arly AMR will be of great beneﬁt to the patients [15] . 
Noise accounts for both measurement error due to inaccuracy
n the MFI readings, and the perpetual actions of many unac-
ounted for factors that inﬂuence the evolution of the system. The
oise intensities I ε were compared between the no-AMR and AMR
roups. Our preliminary study [23] showed a smaller and more
ompact range of the noise intensities from the no-AMR group
ith 9 time series compared with the AMR group with 12 time
eries (shown in Fig. 5 of [23] ). Limited by the numbers of cases
vailable then, the Wilcoxon rank sum test showed no signiﬁcant
ifference in the median value between groups with a p -value of
.08. This study, on a larger cohort with almost twice as many time
eries, conﬁrmed the previous observation with a smaller p -value
f 0.01, indicating a signiﬁcant difference in the median values of
he noise intensity between groups. 
The square root of the noise intensity 
√ 
I ε , which is an absolute
rror value, shares the same unit as the MFI level. In the no-AMR
roup with an average MFI peak height of 5716 AU, the median
nd range (in brackets) for 
√ 
I ε were 159 (5–353) AU. In the AMR
roup with an average MFI peak height of 8502 AU, the median
nd range (in brackets) for 
√ 
I ε were 253 (34–1425) AU. A smaller
oise intensity and more compact range of values across theparameters θ0 , θ1 , θ2 , θ3 . 
post-transplant antibody dynamics in high risk kidney transplan- 
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Fig. 7. Phase portraits of the three dimensional system for two DSA time series, (a) 
from a patient in the AMR group and (b) from a patient in the no-AMR group. The 
time difference between two consecutive markers is one day. 
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g  no-AMR group is noticeable. Even though the assay used to mea-
sure the DSA level in both groups was the same, the relationship
between MFI measurement and the antibody level deviates from
linearity as the antibody level approaches 10,0 0 0 AU. The higher
antibody peak values in the AMR group can therefore introduce
an additional source of measurement error compared with the no-
MR group, explaining the wider range and greater magnitude of
noise intensity seen in the AMR group. Another explanation could
be a different level of model imperfection between the two groups.
The higher level of noise in the AMR group could be caused by
more and/or stronger factors unaccounted for by M 3 . Also it is
worth noticing that the priors for the noise intensity applied in
the inference method are chosen to be weakly informative. A more
informative prior may limit the ﬂexibility of the model, but a care-
fully chosen informative prior could improve the estimation of de-
terministic parameters and parameters related to noise description.
The choice of the priors is not straightforward, and an appropriate
methodology is under development. 
In single antigen bead measurements, another measure, termed
inter-assay coeﬃcient of variability (CV) is often used to indicate the
measurement uncertainty. It is deﬁned as the ratio of the standard
deviation and the mean value of several measurements using sep-
arate assays. In [32] , the inter-assay CV was larger than 20% when
the measurements from seven different labs were compared. In our
model, considering the median value of 
√ 
I ε and the median value
of MFI measurements, the median CV is 13% and 14% for the no-
MR and AMR group respectively, which is less than 20% given in
[32] . 
4.3. Eigenvalues 
The evolution equation Eq. (6) can be transformed into the third
order linear state space model of the form ( 
˙ xt 
x¨ t ... 
x t 
) 
= 
( 
0 1 0 
0 0 1 
−θ1 −θ2 −θ3 
) ( 
x t 
˙ xt 
x¨ t 
) 
+ 
( 
0 
0 
θ0 
) 
(9)
The solution of Eq. (9) is deﬁned by the eigenvalues λ1 , λ2 , λ3 of
the 3 × 3 matrix, the corresponding eigenvectors and three initial
conditions. The sum of the eigenvalues deﬁnes the divergence of
the vector ﬁeld (phase volume V ( t )) in the state space [33] : 
 (t) = V 0 e (λ1 + λ2 + λ3 ) t = V 0 e Rt , (10)
where R can be interpreted as the dissipation rate of DSAs. For all
the time series in the cohort, the dissipation rate is less than zero,
which means that the phase volume shrinks. 
The eigenvalues for every DSA time series were calculated us-
ing the inferred parameters θ1 , θ2 and θ3 . Each DSA time series
in the cohort is characterised by three eigenvalues, one of which is
real, λ1 , and two of which are complex conjugate, λ2 , 3 = λr ± iλi .
All eigenvalues λ1 and the real parts of λ2 and λ3 were nega-
tive, conﬁrming that the system generates stable solutions for each
DSA type, which satisﬁes criterion 4 in Section 3.3 . The system dy-
namics for each DSA demonstrate a decay with some oscillations,
the frequency of which is determined by λi . The dissipation rate
is determined by the real parts of the eigenvalues: R = λ1 + 2 λr .
The characteristic dissipation rate R takes into account the over-
all decay along the path from the peak value down to the steady
state. The steady state of the system is a ﬁxed point, which serves
as an attractor. To visualise the dynamics of DSAs, phase portraits
have been plotted for an AMR case ( Fig. 7 (a)), and a no-AMR case
( Fig. 7 (b)). The trajectories start from the inferred initial states and
evolute to the ﬁxed points in a spiral manner in the phase space. It
can be seen that the dissipation rate in the AMR group ( Fig. 7 (a), R
(a ) = −0 . 81 days −1 ) is faster than in the no-AMR group ( Fig. 7 (b),
R (b) = −0 . 27 days −1 ). Please cite this article as: Y. Zhang et al., A new data-driven model for 
tation, Mathematical Biosciences (2016), http://dx.doi.org/10.1016/j.mbsThe dissipation rates and frequencies of oscillations were com-
ared between the AMR and no-AMR groups for 39 time series. In
he no-AMR group, the median and range (in brackets) for R were
0.42 ( −0.66 − : 0.25) days −1 . In the AMR group, the median and
ange (in brackets) for R were −0.79 ( −3.88 − : 0.15) days −1 . The
omparison of the dissipation rates R between the groups for all
he time series conﬁrmed a signiﬁcantly faster dissipation rate of
SAs in the AMR group than in the no-AMR group with a p -value
f 0.04. 
The imaginary parts of the eigenvalues between AMR and no-
MR groups also showed signiﬁcant differences with a p -value of
.03. In the no-AMR group, the median and range (in brackets) for
i were 0.20 (0.01 : 0.34) days 
−1 . In the AMR group, the median
nd range (in brackets) for λi were 0.28 (0.05 : 0.80) days 
−1 . The
arger values of the imaginary parts in the AMR group represent
 higher frequency of oscillation, which indicates a stronger reg-
lation during the transient antibody response for the patients in
he AMR group. One hypothesis of this regulation is the possible
roduction of a secondary antibody (such as anti-idiotype) which
argets the dramatically increased DSA, resulting in a battling force
etween the DSA production and secondary antibody production
19] . 
Note that the previous study by Higgins et al. [2] investigated
he change in absolute MFI values and in the mean percentage falls
n the AMR and no-AMR groups, and suggested that the falls were
reater in the AMR group compared with the no-AMR group. Our
esults show that not only is the difference in the MFI level be-
ween peak and steady state different between the two groups, but
he rate of change of the fall is faster in the AMR group, also im-
lying a stronger regulation mechanism in this group. 
. Conclusions 
With a unique dataset of DSA time series available, a mathe-
atical model in the form of differential equations has been de-
eloped for the ﬁrst time to describe the dynamic of the ‘falls’
n DSAs for patients with and without AMR episodes. The third
rder linear model was selected as it successfully captured the
ommon features of the falling dynamics in DSAs during the early
ost-transplant stage in the AMR and no-AMR groups. The model
s proved useful in classiﬁcation between two clinically different
roups. Even though the settling level of DSAs, which can be ob-post-transplant antibody dynamics in high risk kidney transplan- 
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 erved from the clinical data, showed no difference between the
MR and the no-AMR groups, all the parameters of the model
both deterministic and stochastic) were found to be signiﬁcantly
ifferent between the two groups. This approach is found to be
seful in capturing properties of antibody evolution from their
eak concentration to ﬁnal settling level and showed that the
ynamic responses are different in AMR and no-AMR groups. A
igher frequency of oscillations and a faster antibody dissipation
ate for the AMR group had been observed from the phase portrait
epicting the trajectories of the system states, and a further test
onﬁrmed signiﬁcant differences between the groups. 
The ﬁndings have important implications for the development
f laboratory assays that might deﬁne the nature of the mecha-
isms responsible for the falls in DSA levels post-transplant, since
 fuller understanding of these mechanisms might allow for pre-
ransplant manipulation of DSA levels and improved clinical out-
omes. This is particularly important with respect to the oscillating
ature of DSA levels, which may reﬂect a system slowly reaching
omeostasis, and may be reﬂected in laboratory measurements. 
Further work might also include modelling in relation to more
etailed characteristics of the antibodies. For example, we have al-
eady shown that the subclasses of IgG are associated with clinical
utcomes, so that measuring the levels of these subclasses at more
ime points might be valuable [34] . The clinical outcome measures
ight also be extended. Since acute AMR is often treatable and
s not always associated with a poor clinical outcome (especially
hen the settling level of DSA is very low), longer term graft sur-
ival could also be considered as an important outcome level. The
ay to day renal function does not always follow DSA levels [8] and
ur understanding of how a graft responds to DSA levels and how
MR evolves is limited. 
This study comprises a pilot research on data-driven model de-
elopment for early post-transplant antibody dynamics, focusing
n one of the typical patterns of a rapid fall following a rapid
ise in DSA after kidney transplantation. Future work will involve
lassifying and modelling the other patterns of the post-transplant
SA dynamics that have been described in section 2; a universal
odel that is capable of describing different dynamics in DSAs is
nder development. 
Details on the data used for analysis are available
rom the University of Warwick institutional repository at
ttp://wrap.warwick.ac.uk/78888/. 
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